Committee examines clinical trials transparency
24 October 2019
The Science and Technology Committee follows up on the Committee's previous report on Research integrity: clinical trials transparency, published in October 2018. This session focuses on the progress UK universities and English NHS trusts have made in reporting clinical trials data. Representatives of regulatory bodies and publishers will also be questioned on barriers to clinical trials transparency.
- Watch Parliament TV: Clinical trials transparency: follow-up
- Inquiry: Clinical trials transparency: follow-up
- Science and Technology Committee
Witnesses
Tuesday 29 October 2019, Committee Room 6, Palace of Westminster
At 9.30 am
- Professor Jane Eddleston, Joint Group Medical Director, Manchester University NHS Foundation Trust
- Professor Nigel Brunskill, Director of Research and Innovation, University Hospitals of Leicester NHS Trust
- Mark Cranmer, Director, Joint Research and Enterprise Services, St George's, University of London and St George's University Hospitals NHS Foundation Trust
- Professor Rupert Pearse, Clinical Director of Research and Development, Queen Mary University of London and Barts Health NHS Trust
- Dr Síle Lane, Head of International Campaigns and Policy, Sense about Science
At 10.30 am
- Dr Martin O'Kane, Head of Clinical Trials Unit, Medicines and Healthcare products Regulatory Agency
- Dr Fiona Godlee, Editor in Chief, British Medical Journal
- Professor Sir Terence Stephenson, Chair, Health Research Authority
- Juliet Tizzard, Director of Policy, Health Research Authority
Further information
Image: Creative Commons